Phibro Animal Health Overview
- Year Founded
-
1946
- Status
-
Public
- Employees
-
2,605
- Stock Symbol
-
PAHC
- Investments
-
9
- Share Price
-
$33.30
- (As of Friday Closing)
Phibro Animal Health General Information
Description
Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.
Contact Information
Website
www.pahc.comCorporate Office
- Glenpointe Centre East, 3rd Floor
- 300 Frank West Burr Boulevard, Suite 21
- Teaneck, NJ 07666-6712
- United States
Corporate Office
- Glenpointe Centre East, 3rd Floor
- 300 Frank West Burr Boulevard, Suite 21
- Teaneck, NJ 07666-6712
- United States
Phibro Animal Health Timeline
Phibro Animal Health Stock Performance
As of 20-Nov-2026, Phibro Animal Health’s stock price is $33.30. Its current market cap is $1.35B with 40.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $33.30 | $34.08 | $28.25 - $60.08 | $1.35B | 40.6M | 231K | $2.54 |
Phibro Animal Health Financials Summary
As of 30-Sep-2026, Phibro Animal Health has a trailing 12-month revenue of $1.54B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 2,157,874 | 1,983,725 | 1,734,895 | 1,103,486 |
| Revenue | 1,540,974 | 1,518,093 | 1,296,215 | 1,017,679 |
| EBITDA | 233,352 | 230,972 | 144,225 | 64,590 |
| Net Income | 102,713 | 99,720 | 48,264 | 2,416 |
| Total Assets | 1,514,722 | 1,501,241 | 1,360,900 | 982,184 |
| Total Debt | 789,127 | 788,767 | 761,552 | 525,459 |
Phibro Animal Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Phibro Animal Health Comparisons
Industry
Financing
Details
Phibro Animal Health Competitors (7)
One of Phibro Animal Health’s 7 competitors is Neogen (Lansing), a Formerly VC-backed company based in Lansing, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neogen (Lansing) | Formerly VC-backed | Lansing, MI | ||||
| Diamond V | Corporate Backed or Acquired | Cedar Rapids, IA | ||||
| Virbac Nederland | Corporation | Barneveld, Netherlands | ||||
| Virbac Österreich | Corporation | Vienna, Austria | ||||
| Zoetis | Corporation | Parsippany, NJ |
Phibro Animal Health Patents
Phibro Animal Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4794544-A1 | Use of zoalene in livestock | Pending | 16-Oct-2023 | ||
| AU-2024283886-A1 | Combination of bacterial strains to inhibit pathogens in animals | Pending | 06-Jun-2023 | ||
| EP-4724077-A1 | Combination of bacterial strains to inhibit pathogens in animals | Pending | 06-Jun-2023 | ||
| US-20240407396-A1 | Combination of bacterial strains to inhibit pathogens in animals | Pending | 06-Jun-2023 | ||
| WO-2024254006-A1 | Combination of bacterial strains to inhibit pathogens in animals | Inactive | 06-Jun-2023 | A23K10/18 |
Phibro Animal Health Signals
Phibro Animal Health Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Phibro Animal Health Investments & Acquisitions (9)
Phibro Animal Health’s most recent deal was a Corporate Asset Purchase with Zoetis (Medicated Feed Additive Product Portfolio) for . The deal was made on 31-Oct-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zoetis (Medicated Feed Additive Product Portfolio) | 31-Oct-2024 | Corporate Asset Purchase | Buildings and Property | ||
| DairyX (Israel) | 01-May-2023 | Early Stage VC | Food Products | ||
| Osprey Biotechnics | 01-Aug-2019 | Merger/Acquisition | Biotechnology | ||
| KoVax | 06-Dec-2018 | Merger/Acquisition | Biotechnology | ||
| Biotay | 11-Sep-2017 | Merger/Acquisition | Food Products |
Phibro Animal Health ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
33.93 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Phibro Animal Health FAQs
-
When was Phibro Animal Health founded?
Phibro Animal Health was founded in 1946.
-
Where is Phibro Animal Health headquartered?
Phibro Animal Health is headquartered in Teaneck, NJ.
-
What is the size of Phibro Animal Health?
Phibro Animal Health has 2,605 total employees.
-
What industry is Phibro Animal Health in?
Phibro Animal Health’s primary industry is Other Commercial Products.
-
Is Phibro Animal Health a private or public company?
Phibro Animal Health is a Public company.
-
What is Phibro Animal Health’s stock symbol?
The ticker symbol for Phibro Animal Health is PAHC.
-
What is the current stock price of Phibro Animal Health?
As of 20-Nov-2026 the stock price of Phibro Animal Health is $33.30.
-
What is the current market cap of Phibro Animal Health?
The current market capitalization of Phibro Animal Health is $1.35B.
-
What is Phibro Animal Health’s current revenue?
The trailing twelve month revenue for Phibro Animal Health is $1.54B.
-
Who are Phibro Animal Health’s competitors?
Neogen (Lansing), Diamond V, Virbac Nederland, Virbac Österreich, and Zoetis are some of the 7 competitors of Phibro Animal Health.
-
What is Phibro Animal Health’s annual earnings per share (EPS)?
Phibro Animal Health’s EPS for 12 months was $2.54.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process